MX2023005761A - Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas. - Google Patents

Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas.

Info

Publication number
MX2023005761A
MX2023005761A MX2023005761A MX2023005761A MX2023005761A MX 2023005761 A MX2023005761 A MX 2023005761A MX 2023005761 A MX2023005761 A MX 2023005761A MX 2023005761 A MX2023005761 A MX 2023005761A MX 2023005761 A MX2023005761 A MX 2023005761A
Authority
MX
Mexico
Prior art keywords
pyridine
pyrazolo
protein kinase
kinase inhibitors
substituted pyrrolo
Prior art date
Application number
MX2023005761A
Other languages
English (en)
Inventor
Xingdong Zhao
Haohan Tan
Qihong Liu
Lihua Jiang
Weibo Wang
Shu Lin
Yunling Wang
Original Assignee
Fochon Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fochon Biosciences Ltd filed Critical Fochon Biosciences Ltd
Publication of MX2023005761A publication Critical patent/MX2023005761A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se proporcionan ciertos inhibidores de BTK, sus composiciones farmacéuticas, y métodos de uso de los mismos.
MX2023005761A 2020-11-17 2021-11-16 Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas. MX2023005761A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063115027P 2020-11-17 2020-11-17
PCT/CN2021/130897 WO2022105746A1 (en) 2020-11-17 2021-11-16 SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3, 4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS

Publications (1)

Publication Number Publication Date
MX2023005761A true MX2023005761A (es) 2023-05-29

Family

ID=81708347

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023005761A MX2023005761A (es) 2020-11-17 2021-11-16 Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas.

Country Status (10)

Country Link
US (1) US20230406856A1 (es)
EP (1) EP4247812A1 (es)
JP (1) JP2023549273A (es)
KR (1) KR20230110286A (es)
CN (1) CN116568686A (es)
AU (1) AU2021383227A1 (es)
CA (1) CA3198254A1 (es)
MX (1) MX2023005761A (es)
TW (1) TW202227437A (es)
WO (1) WO2022105746A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102603581B (zh) * 2005-06-22 2015-06-24 普莱希科公司 作为蛋白质激酶抑制剂的吡咯并[2,3-b]吡啶衍生物
WO2008080001A2 (en) * 2006-12-21 2008-07-03 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
BR112021023607A2 (pt) * 2019-05-31 2022-01-04 Fochon Pharmaceuticals Ltd Derivados de pirrolo[2,3-b]piridina e pirazolo[3,4-b]piridina substituídos por inibidores de proteína quinase
CN112608318B (zh) * 2019-12-16 2023-09-08 成都海博为药业有限公司 一种作为蛋白质激酶抑制剂的化合物及其用途
CN112574200B (zh) * 2021-02-26 2021-06-11 安润医药科技（苏州）有限公司 Btk和/或btk的突变体c481s的小分子抑制剂

Also Published As

Publication number Publication date
AU2021383227A1 (en) 2023-06-22
CA3198254A1 (en) 2022-05-27
WO2022105746A1 (en) 2022-05-27
KR20230110286A (ko) 2023-07-21
AU2021383227A9 (en) 2024-05-02
TW202227437A (zh) 2022-07-16
US20230406856A1 (en) 2023-12-21
CN116568686A (zh) 2023-08-08
EP4247812A1 (en) 2023-09-27
JP2023549273A (ja) 2023-11-22

Similar Documents

Publication Publication Date Title
MX2021014674A (es) Pirrolo [2,3-b] piridina sustituida y derivados de pirazolo [3,4-b] piridina como inhibidores de proteinas quinasas.
NZ766835A (en) Pharmaceutical compounds
MX2020009586A (es) Compuestos de (2-azabiciclo[3.1.0]hexan-2-il)pirazolo[1,5-a]pirimi dina e imidazo[1,2-b]piridazina sustituidos como inhibidores de cinasas trk.
TN2019000107A1 (en) Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors
IL281127A (en) Pyrazolo[3,4-B]pyridine compounds as inhibitors of TAM and MET kinases
MY196474A (en) [1,2,4]Triazolo[1,5-A]Pyridinyl Substituted Indole Compounds
WO2006107771A3 (en) PYRAZOLO[3,4-c]QUINOLINES, PYRAZOLO[3,4-c]NAPHTHYRIDINES, ANALOGS THEREOF, AND METHODS
NZ744349A (en) Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors
EP3577116A4 (en) DERIVATIVES OF N-CYCLOALKYL / HETEROCYCLOALKYL-4- (IMIDAZO [1,2-A] PYRIDINE) PYRIMIDINE-2-AMINE AS THERAPEUTICS
UY37559A (es) Pirazolo[3,4-b]piridina y pirrolo[2,3-b]piridina como inhibidores de la tirosina quinasa de bruton
NO20082757L (no) Substituerte imidazoquinoliner, imidazonaftyridiner og imidazopyridiner, sammensetninger og fremgangsmater
NZ703111A (en) Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
WO2006029115A3 (en) 2-amino 1h imidazo ring systems and methods
TW200612932A (en) Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
NZ628186A (en) Compounds for treating spinal muscular atrophy
NO20082065L (no) Nye imidazo[4,5-b]pyridinderivater som inhibitorer av glykogensyntasekinase 3 for anvendelse ved behandling av demens og neurodegenerative forstyrrelser
TW200407322A (en) Novel imidazopyridines as cyclin dependent kinase inhibitors
GEP20237581B (en) 6,7-dihydro-5h-pyrido[2,3-c]pyridazine derivatives and related compounds as bcl-xl protein inhibitors and pro-apoptotic agents for treating cancer
EP4072548A4 (en) COMPOSITIONS AND METHODS FOR SUBSTITUTED 7-(PIPERAZINE-1-YL)PYRAZOLO[ 1,5-A]PYRIMIDINE ANALOGUES AS INHIBITORS BY KRAS
NZ590922A (en) Piperidine derivatives as jak3 inhibitors
IL281924A (en) Forms of pyrido[2,1-A]pyrimidin-4-one derivatives, their formulations and process for their preparation
HK1112229A1 (en) Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo [1,5- a]pyridines, pyrazolo [1,5-c]pyrimidines and 2h-indazole compounds and 5- cyano, 5-amino, and 5-aminomethyl derivatives of imidazo [1,2-a]pyridines, and imidazo [1,5-a]pyrazines compounds as cyclin dependent kinase inhi
ECSP066767A (es) Derivados 1h-tieno[2,3-c]pirazol útiles como inhibidores de quinasa
MX2019004070A (es) Sistema de extraccion de un sistema de circuito cerrado.
MX2018002916A (es) Metodos, composiciones y usos de nuevos inhibidores de fyn quinasa.